C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective

Myelin loss has a crucial impact on behavior disabilities associated to Multiple Sclerosis (MS) and Ischemic Stroke (IS). Although several MS therapies are approved, none of them promote remyelination in patients, limiting their ability for chronic recovery. With no available therapeutic options, en...

Descripción completa

Detalles Bibliográficos
Autores principales: Pentón-Rol, Giselle, Marín-Prida, Javier, Falcón-Cama, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791033/
https://www.ncbi.nlm.nih.gov/pubmed/29346320
http://dx.doi.org/10.3390/bs8010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791033/
https://www.ncbi.nlm.nih.gov/pubmed/29346320
http://dx.doi.org/10.3390/bs8010015

Ejemplares similares